“…With the trend for increased use of CAM in the general population of adults, CAM use is expected to increase in children over time. The prevalence of CAM use in this sample of children in general pediatrics, pulmonary, and oncology clinics was midrange of the use reported in other studies in the United States (Ang et al, 2005;Braganza et al, 2003;Friedman et al, 1997;Gagnon & Recklitis, 2003;Kelly et al, 2000;Lin et al, 2004;Loman, 2003;McCurdy et al, 2003;Neuhouser et al, 2001;Ottolini et al, 2001;Reznick et al, 2002;Sawani-Sikand, Schbiner, & Thomas, 2002;Wilson & Klein, 2002). Use of CAM in children with sickle cell disease was slightly lower in this sample (47%) compared to children in the Baltimore area (54%; Sibinga et al, 2006), whereas the use of CAM in epilepsy was higher in this sample (62%), compared to 39% use in Canada (Soo et al, 2005).…”